Digital Slide Scanners Market Size, Share & Trends Analysis Report By Product (Automated Digital Slide Scanners, Manual Digital Slide Scanners), By Technology, By Application, By Capacity, By End-Use, By Region, And Segment Forecasts, 2025 - 2030

Digital Slide Scanners Market Size & Trends

The global digital slide scanners market size was estimated at USD 151.28 million in 2024 and is projected to grow at a CAGR of 12.7% from 2025 to 2030. The market is expanding due to advancements in whole slide imaging (WSI), increasing adoption of digital pathology, and rising demand for remote diagnostics. Key driving factors include AI-powered analysis, improved workflow efficiency, and the growing need for high-resolution imaging in clinical and research applications. Additionally, telepathology, enhanced data storage, and automation in diagnostics are accelerating market growth, making digital slide scanners essential in modern pathology.

Digital pathology (DP) has been widely used for years in industrial and academic research. Image analysis techniques, including quantification, have been refined over the past decades. Recently, there has been growing interest in leveraging DP for whole slide imaging (WSI) in primary diagnosis, particularly as regulatory agencies increasingly recognize its potential. In Europe, several digital pathology systems (DPS) have received approvals, facilitating the widespread adoption of digital workflows. Countries such as the Netherlands, Sweden, England, and Spain have made significant advancements, with some achieving full-scale digital transformation in pathology practices. In North America, Canada has been progressing steadily since the early 2010s, while in the United States, the Food and Drug Administration (FDA) has approved multiple WSI systems, signaling a crucial shift in regulatory acceptance and market expansion.

Whole slide imaging represents a transformative innovation in pathology, serving as a foundational step for various digital tools to enter the field. The primary function of WSI is to digitize glass slides, but its broader impact extends to workflow optimization, increased reproducibility, enhanced educational dissemination, and improved accessibility to pathology services in underserved regions. Furthermore, WSI promotes seamless intra-institutional and inter-institutional collaboration, driving efficiency across healthcare networks. Despite these advantages, the widespread adoption of digital slide scanners remains challenging due to the complexities of implementation, high initial investment costs, and the need for robust IT infrastructure.

One of the primary barriers to WSI adoption is the reluctance of institutions unfamiliar with the necessary technological frameworks or those struggling to justify the investment to executive leadership. Many healthcare organizations face challenges in articulating the benefits of digital slide scanning systems, particularly in environments where immediate reimbursement opportunities are unclear. However, with the increasing recognition of DP and its integration into clinical workflows, there is a gradual reduction in resistance to adoption. As more institutions witness the long-term efficiencies and clinical benefits, digital slide scanners are becoming an essential component of modern pathology.

The digital slide scanners market is a critical segment within the broader tissue diagnostics industry. As regulatory approvals increase and technological advancements improve scanner precision and data management capabilities, the market is poised for substantial growth. The ongoing shift towards AI-powered image analysis, cloud-based data storage, and interoperability with laboratory information systems further strengthens the case for digital pathology solutions. With the global healthcare landscape evolving towards digital transformation, investments in digital slide scanners are expected to rise, reinforcing their role in the future of pathology diagnostics.

Market Opportunities for Digital Slide Scanners in Tissue Diagnostics

Tissue diagnostics is a critical field in healthcare, enabling the identification and characterization of diseases such as cancer, infections, and autoimmune disorders through the microscopic examination of tissue samples. The demand for precision diagnostics, faster turnaround times, and improved accuracy are driving the adoption of digital solutions, with digital slide scanners emerging as a transformative technology within this market.

Digital slide scanners convert glass slides containing tissue samples into high-resolution digital images, facilitating remote access, AI-driven analysis, and enhanced workflow efficiency.

Market Concentration & Characteristics

The digital slide scanner market is marked by a high degree of innovation, driven by AI-powered image analysis, automation, and telepathology advancements. Companies like Philips, Roche, and Paige.AI are integrating machine learning, cloud storage, and real-time collaboration tools, enhancing diagnostic accuracy, workflow efficiency, and remote accessibility in tissue diagnostics.

The digital slide scanner market has seen a surge in M&A activities, driven by the increasing adoption of AI-powered diagnostics, telepathology, and workflow automation. Companies are acquiring startups specializing in machine learning, cloud-based pathology platforms, and automated image analysis to strengthen their market position. Notably, 3DHISTECH acquired software firms to expand its AI-driven solutions, while Hamamatsu Photonics invested in digital imaging technologies to enhance precision diagnostics. Additionally, Indica Labs partnered with biotech firms to integrate computational pathology, highlighting the growing trend of consolidation in the industry.

Regulations play a crucial role in shaping the digital slide scanner market, affecting product approvals, market adoption, and innovation. Regulatory bodies like the FDA (U.S.), CE Mark (Europe), and CFDA (China) enforce strict guidelines to ensure diagnostic accuracy, patient safety, and data security. Compliance with HIPAA, GDPR, and CAP (College of American Pathologists) is essential for handling patient data and telepathology applications. Stringent approval processes can slow market entry but also enhance credibility. Recent FDA approvals for AI-powered digital pathology solutions highlight the increasing regulatory support for innovation in clinical diagnostics.

In the digital slide scanner market, product substitutes include traditional glass slide microscopy, frozen section analysis, and molecular diagnostics. While conventional light microscopy remains widely used, it lacks the efficiency and remote accessibility of digital solutions. Frozen section analysis provides rapid intraoperative diagnoses but is limited by lower image quality. Molecular diagnostics, including liquid biopsy and genetic sequencing, can serve as an alternative for certain conditions but do not fully replace histopathology. Despite these substitutes, digital slide scanners offer superior workflow efficiency, AI integration, and telepathology capabilities, making them a preferred choice.

The digital slide scanner market exhibits a high level of end-user concentration, primarily driven by demand from hospitals, diagnostic laboratories, research institutions, and pharmaceutical companies. Large healthcare networks and academic medical centers account for a significant portion of adoption, as they require high-throughput scanning, AI-powered diagnostics, and telepathology integration. Reference laboratories and contract research organizations (CROs) also contribute to market growth by utilizing digital pathology for clinical trials and Automated Digital Slide Scanners research. While adoption is growing in smaller pathology labs, the market remains concentrated among large-scale institutions with higher diagnostic volumes and technology budgets.

New Technology and Adoption Landscape of Digital Slide Scanners in Tissue Diagnostics

The digital slide scanner market in tissue diagnostics is undergoing rapid transformation, driven by advancements in AI, whole slide imaging (WSI), telepathology, and automation. These innovations are improving diagnostic accuracy, workflow efficiency, and accessibility, leading to increased adoption across hospitals, research institutions, and diagnostic laboratories.

New Technology and Adoption Landscape of Digital Slide Scanners in Tissue Diagnostics:

• AI & Machine Learning: AI-powered image analysis, tumor detection, and pattern recognition are enhancing pathology workflows.

  • Example: NanoZoomer S360MD (Hamamatsu) - AI-ready scanner for clinical pathology.

• Whole Slide Imaging (WSI): High-resolution scanning with automated focus and color correction is now a standard in tissue diagnostics.

  • Example: 3DHISTECH Pannoramic 1000 - High-capacity, high-speed WSI scanner.

• Cloud-Based Digital Pathology: Enables remote access, telepathology, and real-time collaboration among pathologists worldwide.

  • Example: OptraSCAN OS-Ultra - Cloud-enabled whole slide scanner with AI integration.

• Automated Workflow & LIS Integration: AI-powered case Brightfield Scanners and auto-scanning improve efficiency in high-throughput labs.

  • Example: Huron Digital Pathology AI Scanner - Seamless LIS integration for automated scanning.

• Portable & Compact Scanners: Miniaturized WSI scanners for decentralized and mobile diagnostics are gaining popularity.

  • Example: Grundium Ocus 40 - Portable digital slide scanner for telepathology.

Adoption Trends:

• High adoption in oncology diagnostics, academic research, and CROs.

• Growing demand for AI-powered and cloud-enabled scanners.

• Regulatory compliance (FDA, CE, HIPAA) is critical for clinical adoption.

These technologies and new product innovations are reshaping tissue diagnostics, enabling faster, more precise, and remote pathology workflows.

Case Study Summary: Roche VENTANA DP 200 - Advancing Digital Pathology with FFEI

Introduction

Roche Tissue Diagnostics partnered with FFEI to develop the VENTANA DP 200, a high-speed, high-quality digital slide scanner designed to enhance digital pathology workflows and support AI-driven diagnostics.

Technology & Innovation

FFEI contributed:

• High-speed scanning (less than 49 seconds for a 15x15mm scan).

• Dynamic focus tracking for consistent image clarity.

• DICOM compatibility for seamless integration with pathology systems.

• ICC color profiling, ensuring accurate color matching.

Key Quote

Vice President & Lifecycle Leader, Roche Digital Pathology:

"FFEI’s technical acumen and experience in high-quality scanning and color reproduction have been invaluable in the successful development of the DP 200 slide scanner. Roche looks forward to building on this success as it continues its partnership with FFEI."

Managing Director, FFEI:

"The collaboration between Roche’s market expertise and FFEI’s digital imaging technology has resulted in a truly unique, market-leading product."

Results & Impact

• Enhanced efficiency & reduced scan errors through tray-based slide handling.
• AI-ready technology for advanced digital pathology applications.

Conclusion

The VENTANA DP 200 sets new standards in clinical and research pathology, ensuring faster, more accurate diagnostics.

Product Insights

The automated digital slide scanners accounted for the largest revenue share of 57.2% in 2024. The segment is witnessing significant growth in the tissue diagnostics market, driven by advancements in AI-powered imaging, telepathology, and workflow automation. These scanners are transforming pathology by improving efficiency, accuracy, and scalability, making them essential for hospitals, research institutions, and diagnostic laboratories. The increasing prevalence of cancer and other tissue-related diseases has created a demand for faster and more precise diagnostic solutions, leading to the widespread adoption of automated digital slide scanners.

A key driving factor is the growing workload on pathologists, which has resulted in the need for solutions that reduce manual intervention while maintaining diagnostic precision. Automated digital slide scanners streamline pathology workflows by enabling high-speed scanning, real-time image analysis, and remote access to digital slides, making pathology services more efficient and accessible. Another major factor is the integration of AI and machine learning, which allows for automated detection, classification, and quantification of tissue abnormalities. AI-powered scanners can assist in tumor grading, Automated digital slide scanners detection, and personalized treatment planning, enhancing diagnostic confidence.

An example of innovation in this segment is the 3DHISTECH Pannoramic 1000, a high-speed, automated whole slide scanner designed for large-scale pathology labs. This system offers AI-assisted image analysis, seamless integration with laboratory information systems (LIS), and high-throughput scanning capabilities, significantly improving diagnostic efficiency. As the demand for digital pathology solutions continues to rise, automated digital slide scanners will play a crucial role in shaping the future of tissue diagnostics and precision medicine.

Technology Insights

The brightfield scanners segment dominated the market and accounted for the largest share of 69.9% in 2024. Brightfield scanners use traditional light microscopy techniques to create high-resolution digital images of stained tissue samples, making them widely used in histopathology, oncology, and research applications. The demand for faster, more accurate, and scalable diagnostic solutions has fueled the adoption of these scanners, particularly in clinical laboratories and academic institutions.

One of the primary market drivers for brightfield scanners is the growing incidence of cancer and other tissue-related diseases, which has increased the need for efficient diagnostic tools. As pathology workloads continue to rise, laboratories require high-throughput scanners that can rapidly digitize large volumes of slides while maintaining image quality. The shift towards digital pathology and telepathology has further accelerated the adoption of brightfield scanners, enabling remote diagnosis, collaboration between experts, and seamless integration with AI-powered diagnostic tools. Advances in image processing and whole slide imaging (WSI) have also played a significant role in the market's expansion, allowing pathologists to examine tissue samples with greater precision.

Additionally, the fluorescence scanners segment is the fastest-growing category in the digital slide scanners market, driven by advancements in molecular pathology, Automated Digital Slide Scanners research, and precision medicine. Unlike brightfield scanners, fluorescence scanners use fluorophore-labeled markers to detect specific proteins, DNA, and cellular structures, making them essential for immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), and multiplexed tissue analysis. Their ability to provide high-contrast, multi-channel imaging has significantly improved the detection of cancer, neurological disorders, and infectious diseases. An example of a leading fluorescence scanner is the PerkinElmer Vectra Polaris, which offers high-throughput, multiplexed fluorescence imaging for tissue diagnostics. With its ability to analyze multiple Automated Digital Slide Scanners in a single tissue section, it has become a vital tool for cancer research, immuno-oncology, and translational medicine, reinforcing the segment’s rapid growth.

Application Insights

The clinical diagnostics segment dominated the application segments with the largest market share of 42.92% in 2024. The integration of digital slide scanners in clinical diagnostics is revolutionizing tissue diagnostics, offering faster, more accurate, and reproducible results. With rising global healthcare demands, the need for efficient, high-throughput diagnostic solutions has driven laboratories and hospitals to adopt digital pathology workflows. The transition from traditional microscopy to whole slide imaging (WSI) is allowing clinicians to remotely analyze and share high-resolution tissue samples, improving patient outcomes and streamlining pathology operations.

One of the key driving factors behind this shift is the increasing prevalence of chronic diseases, particularly cancer, which requires rapid and precise histopathological analysis. The growing adoption of AI-powered diagnostic tools has further fueled market expansion, enabling automated pattern recognition, anomaly detection, and predictive analytics in pathology. Regulatory approvals for primary digital diagnosis, such as the FDA clearance for whole slide imaging systems, have strengthened confidence in digital scanners for clinical use.

Capacity Insights

The Scanner 61-299 slides capacity segment dominated the capacity segments with the largest market share of 45.03% in 2024. The medium-capacity scanner segment (61-299 slides) is a rapidly expanding category in the digital pathology market, catering to hospitals, diagnostic laboratories, and research institutions that require high-speed, high-quality whole slide imaging without the need for ultra-high-capacity solutions. These scanners strike a balance between efficiency, affordability, and automation, making them ideal for mid-to-large-scale pathology operations transitioning to digital workflows.

A standout example in this segment is the OS-Ultra Whole Slide Scanner, which is setting new standards in digital pathology scanning with its lightning-fast imaging capabilities. It can scan a 15x15 mm area at 40x magnification in under 60 seconds, ensuring exceptional speed without compromising image quality. Its no-touch slide loading mechanism minimizes workflow errors. At the same time, integrated software solutions like IMAGEPath for image management and TELEPath for remote telepathology consultations make it a powerful tool for real-time diagnostics and collaboration. The OS-Ultra is revolutionizing tissue and cellular analysis in pathology labs worldwide with its advanced features.

Moreover, the digital slide scanners (300+ slides) is expected to grow at the fastest rate. The growing demand for high-capacity digital slide scanners (300+ slides) is transforming tissue diagnostics, particularly in high-throughput pathology labs, pharmaceutical research, and large-scale clinical diagnostics. These scanners are designed to efficiently handle large volumes of tissue samples, enabling faster diagnoses, AI-driven analysis, and improved workflow automation. The transition from traditional microscopy to whole slide imaging (WSI) has driven the need for scalable, high-speed solutions that reduce manual labor and enhance diagnostic accuracy.

End-use Insights

The hospitals & clinical pathology labs segment dominated the end-use segments with the largest market share of 36.44% in 2024. Hospitals and clinical pathology labs are rapidly adopting digital slide scanners to enhance efficiency, accuracy, and accessibility in tissue diagnostics. The transition from traditional microscopy to whole slide imaging (WSI) enables pathologists to analyze samples digitally, improving workflow automation, remote collaboration, and AI-assisted diagnostics. With the rising global burden of cancer and other tissue-related diseases, hospitals require faster, high-throughput solutions to manage increasing case volumes. Digital slide scanners streamline pathology workflows, reducing turnaround times and minimizing human errors. Additionally, telepathology capabilities allow specialists to share cases instantly, enhancing diagnostic accuracy and enabling expert consultations across locations.

Moreover, the digital slide scanners (300+ slides) is expected to grow at the fastest rate at the CAGR of 17.36%. Contract Research Organizations (CROs) are increasingly leveraging digital slide scanners to enhance efficiency, scalability, and data accuracy in outsourced tissue diagnostics. As pharmaceutical and biotech companies accelerate drug development, Automated Digital Slide Scanners discovery, and clinical trials, CROs play a critical role in providing high-throughput pathology services using automated whole slide imaging (WSI) and AI-powered analytics.

The demand for remote collaboration, regulatory compliance, and faster turnaround times has driven CROs to adopt digital pathology workflows, enabling pathologists to analyze slides remotely and integrate findings seamlessly with clinical trial data. AI-assisted image analysis and machine learning algorithms further enhance accuracy, allowing for automated tissue segmentation, tumor grading, and Automated Digital Slide Scanners quantification in large-scale studies.

Regional Insights

North America digital slide scanners market dominated the market and accounted for a 44.76% share in 2024. The increasing adoption of digital pathology is a primary driver, as it facilitates the digitization of glass slides, enabling remote consultations and efficient data storage. This shift enhances diagnostic accuracy and operational efficiency in healthcare settings. Technological advancements in medical imaging, such as higher resolution imaging and faster scanning speeds, are also contributing to market expansion. These innovations improve the quality and speed of diagnostic processes, making digital slide scanners more appealing to healthcare providers. Additionally, the growing prevalence of chronic diseases, including cancer, necessitates advanced diagnostic tools, further propelling the demand for digital slide scanners.

U.S. Digital Slide Scanners Market Trends

The U.S. digital slide scanner market is experiencing significant growth, driven by technological advancements and increasing adoption in medical diagnostics. The integration of artificial intelligence (AI) and deep learning algorithms into digital slide scanners is a key trend, enabling automated image analysis and interpretation, thereby enhancing diagnostic accuracy and efficiency. Additionally, the rising adoption of cloud-based digital pathology solutions facilitates remote access to digital slide images, seamless collaboration among healthcare professionals, and centralized data storage for large-scale analysis. These developments are transforming traditional pathology workflows, making them more efficient and accurate.

Europe Digital Slide Scanners Market Trends

The European digital slide scanners market was identified as a lucrative region in this industry. Increasing adoption of digital pathology among healthcare professionals and research institutions is driving the growth of the market. The European digital pathology market is highly competitive, with multiple players such as Leica Biosystems, Hamamatsu Photonics, 3DHISTECH, and others offering different types of scanners and imaging solutions. Key players are further focusing on developing more advanced AI-powered analysis tools, as well as expanding their geographic reach.

The UK digital slide scanner market is experiencing significant growth, driven by the increasing adoption of digital pathology solutions. This shift enhances diagnostic accuracy and efficiency, aligning with the UK's emphasis on integrating advanced technologies into healthcare practices. The integration of artificial intelligence (AI) and deep learning algorithms into digital slide scanners is a notable trend, enabling automated image analysis and interpretation, thereby improving diagnostic accuracy and efficiency. Additionally, the rising prevalence of chronic diseases necessitates advanced diagnostic tools, further driving the demand for digital slide scanners in the UK.

The German digital slide scanner market is experiencing significant growth, driven by advancements in imaging technology and increasing adoption of AI-powered pathology solutions. The demand for remote diagnostic capabilities has accelerated the use of digital slide scanners, enabling telepathology and seamless collaboration among healthcare professionals. The expansion of digital pathology services in hospitals and research institutions is further contributing to market growth. Companies such as ZEISS, Leica Biosystems, and Hamamatsu Photonics are investing in innovative solutions to enhance diagnostic accuracy and workflow efficiency. Additionally, supportive government initiatives and regulatory advancements are encouraging the integration of digital pathology into routine clinical practices.

Asia Pacific Digital Slide Scanners Market Trends

Asia Pacific digital slide scanners market is anticipated to witness the fastest growth of 13.7% CAGR over the forecast period. The Asia-Pacific digital slide scanner market is experiencing significant growth, driven by technological advancements in digital pathology and increasing healthcare investments. The rising prevalence of chronic diseases necessitates advanced diagnostic tools, further propelling market expansion. Opportunities abound in emerging markets like China and India, where healthcare infrastructure is rapidly developing, and there is a growing demand for innovative diagnostic solutions.

The digital slide scanner market in China is experiencing significant growth, driven by technological advancements in digital pathology and the increasing adoption of telemedicine. The integration of artificial intelligence (AI) into digital pathology systems is enhancing diagnostic accuracy and workflow efficiency, leading to broader acceptance among healthcare providers. Additionally, the rising prevalence of chronic diseases necessitates advanced diagnostic tools, further propelling the demand for digital slide scanners. Key players such as ZEISS, Leica Biosystems, and Hamamatsu Photonics are actively contributing to this market expansion by offering innovative solutions tailored to the needs of medical and research institutions.

The Japan digital slide scanners market is experiencing steady growth, driven by advancements in pathology, telemedicine, and AI integration. Increased demand for high-resolution imaging, automation, and efficient diagnostic tools in healthcare is propelling adoption. Key trends include compact designs, cloud-based solutions, and enhanced compatibility with digital pathology systems, catering to hospitals, labs, and research institutions.

Latin America Digital Slide Scanners Market Trends

Latin America digital slide scanners market is anticipated to grow at a substantial growth rate over the forecast period. The Latin America digital slide scanners market is growing due to increasing adoption of digital pathology, rising healthcare investments, and demand for accurate diagnostics. Key trends include the integration of AI for image analysis, cloud-based storage solutions, and portable scanner designs. Expanding telemedicine and government initiatives to modernize healthcare infrastructure are also driving market growth, particularly in Brazil, Mexico, and Argentina.

The Brazil digital slide scanners market is witnessing growth driven by advancements in healthcare infrastructure, increasing adoption of digital pathology, and rising demand for precise diagnostic tools. Key trends include the integration of AI for enhanced image analysis, adoption of cloud-based solutions for data storage, and a focus on cost-effective, portable scanners. Government initiatives and private sector investments are further fueling market expansion.

Middle East and Africa Digital Slide Scanners Market Trends

The Middle East and Africa (MEA) digital slide scanners market is expanding due to improving healthcare infrastructure, rising prevalence of chronic diseases, and growing adoption of digital pathology. Key trends include increased investment in telemedicine, demand for high-resolution imaging, and integration of AI for diagnostic accuracy. GCC countries, South Africa, are leading the adoption, supported by government initiatives and private sector partnerships.

The Saudi Arabia digital slide scanners market is growing rapidly, driven by the government's Vision 2030 initiative to modernize healthcare infrastructure. Key trends include increased adoption of digital pathology, integration of AI for advanced diagnostics, and demand for high-resolution imaging. For example, hospitals like King Faisal Specialist Hospital are leveraging digital scanners for efficient cancer diagnostics and telepathology collaborations. Cloud-based solutions and portable scanners are also gaining traction.

Key Digital Slide Scanners Company Insights

Some of the key players operating in the market include Hamamatsu Photonics, 3DHISTECH, Leica Biosystems (Danaher Corporation), Olympus Corporation, Roche Digital Pathology (Ventana Medical Systems), Indica Labs. New product launch, mergers and acquisitions, and collaborations are some of the major strategies adopted by these players to counter the stiff competition.

Recent Developments

• In January 2025, Roche announced that its whole slide imaging system, Roche Digital Pathology Dx, has received an additional 510(k) clearance from the U.S. Food and Drug Administration (FDA). This clearance builds upon the initial approval granted on June 14, 2024, for Roche Digital Pathology Dx, which includes the VENTANA DP 200 slide scanner, Roche's digital pathology workflow software, and a display. The latest clearance now incorporates the VENTANA DP 600 slide scanner. The VENTANA DP 600 is a high-capacity slide scanner that generates high-resolution digital images of stained tissue samples, aiding clinicians in diagnosing cancer and determining appropriate treatment plans for patients.

• In July 2024, Grundium introduced the Ocus M 40, its first multi-slide scanner, marking an expansion beyond its single-slide scanner lineup. Developed in response to user feedback, the Ocus M 40 supports scanning up to four slides simultaneously, catering to the needs of pathology professionals requiring multi-slide capabilities. Despite its increased capacity, the device maintains Grundium’s signature compact size and familiar form factor.

• In September 2024, Vieworks, a prominent player in bioimaging solutions, is set to redefine digital pathology with the launch of its high-speed slide scanner, LUCEON 510. The company will make its debut as a digital pathology solution provider at the European Congress of Pathology (ECP) 2024, a leading event in the field, taking place in Florence, Italy, from September 7th to 10th at Booth 39.

Digital Slide Scanners Market Report Scope

Global Digital Slide Scanners Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global digital slide scanners market report based on product, application, technology, capacity, end use, region

• Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Automated Digital Slide Scanners

  • Manual Digital Slide Scanners

• Technology Outlook (Revenue, USD Million, 2018 - 2030)

  • Brightfield Scanners

  • Fluorescence Scanners

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Clinical Diagnostics

  • Research & Drug Discovery

  • Forensic Pathology

  • Others

• Capacity Outlook (Revenue, USD Million, 2018 - 2030)

  • Scanner 1-60 slides capacity

  • Scanner 61-299 slides capacity

  • Scanner >300 slides capacity

• End Use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals & Clinical Pathology Labs

  • Biopharmaceutical & Biotech Companies

  • Academic & Research Institutes

  • Contract Research Organizations (CROs)

• Regional Outlook (Revenue in USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Sweden

    • Denmark

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa

    • Saudi Arabia

    • South Africa

    • UAE

    • Kuwait